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Abstract
Acute abdominal pain is one of the most frequent reasons for admitting patients to the emergency department
for surgical evaluation. A wide number of differential diagnoses are available and their pre-test likelihood ratio
varies according to the patients’ age, gender, duration of symptoms and overall clinical context. While many
patients with abdominal pain do not need to be admitted to the hospital wards and even fewer need eventual
surgical intervention, the diagnosis of acute appendicitis remains one of the most frequently entertained
differential in patients with abdominal pain. In fact, surgery for appendicitis is one of the most frequently
performed operations in the Western world. As the authors of the current study point out, the high mobility group
box-1 protein (HMGB1) has been known for many years. The study demonstrates in a small pilot that there is a
difference in expression of HMGB1 between those with and those without appendicitis. However, is this difference
clinically important? Clinically relevant results can only be documented through larger studies comparing its use
and expression levels in both healthy subjects, subjects with abdominal pain for other reasons, patients with ‘clear-
cut’ (histopathologically confirmed) appendicitis and in the difficult subgroup of patients with suspected
appendicitis and equivocal symptoms.
Acute abdominal pain is one of the most frequent rea-
sons for admitting patients to the emergency department
for surgical evaluation. A wide number of differential
diagnoses are available and their pre-test likelihood ratio
varies according to the patients’ age, gender, duration of
symptoms and overall clinical context. While many
patients with abdominal pain do not need to be admitted
to the hospital wards and even fewer need eventual surgi-
cal intervention, the diagnosis of acute appendicitis
remains one of the most frequently entertained in
abdominal pain. In fact, surgery for appendicitis is one of
the most frequently performed operations in the Western
world. Even today, with current advances in diagnostic
imaging and the ever increasing use of laparoscopy, the
patient with ‘suspected appendicitis’ represents a diag-
nostic challenge. Indeed, early diagnosis remains the
most important clinical goal in patients with suspected
appendicitis. Large scale studies have demonstrated that
while the rates of ‘negative’ (or ‘unnecessary’) appendec-
tomies do decline, the rates of perforation remains fairly
constant at about 15% [1]. Perforated appendicitis repre-
sents a major disease burden for both patient and society,
and comes with added morbidity and complications.
While appendicitis is not as dreaded now as it was a cen-
tury ago, mortality is still reported in about 1% of
patients. Risk factors are not completely understood
more than 100 years after its first description [2]. The
d i a g n o s i si ss t i l lb a s e do nc l i nical examination, optional
imaging studies and blood laboratory tests [3,4]. To the
latter category belongs white blood cell counts (WBC)
a n dC - r e a c t i v ep r o t e i n( C R P )a st w oo ft h em o s tf r e -
quently evaluated blood test, yet none of them are confir-
mative for appendicitis as they may either be elevated,
within a normal range or associated with other diseases.
Thus, the current study published in the SJTREM by
Albayrak et al [5] is important for a number of reasons. Correspondence: ksoreide@mac.com
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markers would potentially have great impact on work-
up and use of diagnostic imaging if accurate and predic-
tive of disease. In particular this is useful in patients
whose clinical symptoms are equivocal. Second, genomic
and proteomic biomarkers may shed new light on dis-
ease processes needed to discern differences in aetiology
and pathogenesis which may eventually help us under-
stand this disease better. Finally, a drive towards non-
operative management of “non-complicated” appendici-
tis has been advocated through randomised controlled
trials recently [6]. However, of concern is the fact that
at current diagnostic tools are non-specific so one can-
not at present reliably confirm that appendicitis is the
true entity that is being treated in such trials. Conse-
quently, the results are not generalisable and not imme-
diately valid nor advisable for use in the general
population at large [7,8].
As the authors of the current study point out [5], the
high mobility group box-1 protein (HMGB1) has been
known for many years as a nuclear chromosomal pro-
tein. Its role as a pro-inflammatory cytokine in sepsis
and rheumatoid arthritis has been described, and more
recently its role in community-acquired infections and
sepsis investigated [9].
HMGB1 is an intracellular protein that can translocate
to the nucleus where it binds DNA and regulates gene
expression. It can also be released from cells, in which
extracellular form it can bind to an inflammatory recep-
tor called Receptor for Advanced Glycan Endproducts
(RAGE). Activated macrophages and monocytes secrete
HMGB1 as a cytokine in inflammation. The mechanism
of inflammation and damage is binding to toll-like
receptor 4 (TLR4), which mediates HMGB1-dependent
activation of macrophage cytokine release. This posi-
tions HMGB1 at the intersection of sterile and infec-
tious inflammatory responses. Thus, the increased level
of HMGB1 likely reflects a systemic inflammatory
response syndrome (SIRS) in patients with appendicitis,
that may resemble the same or similar mechanisms as
previously detailed for trauma patients and following
post-injury events [10-13]. However, the jump from
molecular mechanisms that may be a central player, or
just a bystander effect, of the primary insult, is a rela-
tively premature closure. As Stahel and colleagues high-
lighted for mechanisms explored in injury [10], the
metabolic effects are characterized by a network of
interactions, and cross-linkage and cross-over effects of
which it is extremely hard if not possible to predict an
outcome based on one sole player amongst the mingling
molecules.
T h ed i a g n o s t i cv a l u eo fH M G B 1l e v e l sw a si n v e s t i -
gated using ROC curve analysis in this study by
Albayrak et al [5]. The use of ROC analysis is an
appropriate method in evaluation for various biomarkers
[14,15]. The curve shows that a high discriminative abil-
ity was not obtained, although levels between diseased
patients and controls differed significantly. For the diag-
nosis of acute appendicitis, the best cut-off point for
HMGB1 was at 25 ng/ml. The calculated sensitivity,
specificity, positive predictive value and negative predic-
tive value were calculated as 72%, 73%, 88% and 45%,
respectively (area under curve = 0.781), which is not
comparably better to the accuracy of WBC or CRP
already in clinical use [16]. So it appears, as testing for
HMBG1 is not readily available 24-7-365 in most clini-
cal chemistry labs, nor demonstrable cheaper or more
cost-efficient than other available tests, it will not
replace a standard work-up panel as of yet.
Nonetheless, the current study demonstrates that
there is a difference in expression of HMGB1 between
those with and those without appendicitis. Whether the
question under investigation will give clinically impor-
tant answers can only be addressed through future, lar-
ger studies comparing the use and expression levels of
HMGB1 in both healthy subjects, subjects with abdom-
inal pain for other reasons, patients with ‘clear-cut’ (his-
topathologically confirmed) appendicitis and in the
difficult subgroup of patients with suspected appendici-
tis and equivocal symptoms. Whether this may truly
prove a useful diagnostic biomarker among the increas-
ing number of alternatives investigated [17-19], or
merely be yet another blind alley in the surge for the
correct diagnosis of acute appendicitis remains to be
seen.
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